🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats Dr. Rosenberg!

Congrats Paula Ferrada MD FACS FCCM MAMSE and InovaFFXTrauma1, what a privilege is is to train in an environment that embraces change. We have already seen it here; this paradigm shift will save lives.

Steven Rosenberg (National Cancer Institute): “We’re now working hard to bring this new kind of treatment using a patient’s own cells to patients with metastatic solid epithelial cancers—the kinds of cancers that cause 90% of all deaths from cancer today.” cancerletter.com/conversation-w…

Discover #HotJACS, currently trending articles from JACS. 🔥 Prioritizing Circulation to Improve Outcomes for Patients with Exsanguinating Injury: A Literature Review and Techniques to Help Clinicians Achieve Bleeding Control Read the full article: journals.lww.com/journalacs/ful…

First all female class graduating soon! Our residents are amazing. Congratulations to all of you who are moving onto your respective fellowships! WomenSurgeons

Feels appropriate to end Chief-year with 7 whipples in 10 days. Thankful for all of the mentorship from both the Inova Surgery Residents and NIH faculty over the past 8-years. Next stop Moffitt Cancer Center

Had a great morning connecting with our surgical fellows Moffitt Cancer Center over breakfast. Appreciate their dedication to shaping the field and advancing cancer care. Karen Lu

The best part of academic surgery is the friends we make through collaboration. Thank you to Alessandro Gronchi for being our Visiting Professor at Moffitt Cancer Center before #SSO2025 and sharing your time with our fellows. TARPSWG Society of Surgical Oncology

Live from #SSO2025: Leah Hendrick, MD, surgical oncology fellow, joins Sean Dineen, MD to discuss the unique opportunities offered by Moffitt's Complex General Surgical Oncology Fellowship and shares advice for surgical oncology applicants. #MoffittSSO25

At #SSO2025, Jason Denbo, MD (Jason W Denbo) joined Daniel Anaya, MD (Daniel Anaya) to discuss the latest surgical techniques for hepatobiliary tumors and his work mentoring future surgical oncologists. #MoffittSSO25

First year Moffitt Cancer Center GCSO fellows take #SSO2025

Join Seth Felder, MD and Daniel Anaya, MD (Daniel Anaya) at #SSO2025 as they breakdown Moffitt's collaborative approach to rectal cancer care and personalized treatment. #MoffittSSO25

Behind the scenes: Carlos I Ayala-Navarro, MD PhD presenting his work on the immunosuppressed environment in appendiceal cancers here at #SSO2025 Moffitt Cancer Center

During #SSO2025 Carlos Ayala-Navarro (Carlos I Ayala-Navarro, MD PhD) presents on immune microenvironment in appendiceal cancers. Key findings include increased MUC2 cells in tumors, reduced populations of B, T, and regulatory T cells, and an increased presence of neutrophils, macrophages, and

At #SSO2025, Sean Dineen, MD, joined me to discuss the advanced techniques used to treat peritoneal disease, which is a rare manifestation where cancer spreads from its site of origin into the lining of the abdominal cavity. #MoffittSSO25

#FollowFriday Meet Apeksha Dave, MD (Apeksha), a Complex General Surgical Oncology (CGSO) fellow. Her research centers on understanding why patients respond differently to therapies and exploring ways to personalize treatments to improve patient outcomes. In the future, she

Moffitt Cancer Center research symposium. Great talks by dozens of talented trainee researchers and clinicians. Our rockstar research fellow, who will wind up publishing 20+ papers during her research fellowship!!, Michelle M. Dugan, MD presenting our IO vs TVEC vs ILI for intransit disease.

Great talk here at the #MoffittCancerSymposium by my co-fellow Dr Gazivoda discussing our experience with robotic-assisted prophylactic total gastrectomy for patients with CDH1 mutations Moffitt Cancer Center

At the 2025 #MoffittScientificSymposium Victor Gazivoda, MD presents on Prophylactic Robotic Assisted Total Gastrectomy as a safe practice with outcomes similar to open and laparoscopic approaches in patients with hereditary diffuse gastric cancer.

Thanks for the opportunity to present our findings